Mifestad 10 STADA PLAN B EMERGENCY CONTRACEPTIVE 120 HOURS AFTER INTERCOURSE
Each tablet contains mifepristone 10 mg.
Indications and Dosage & Administration
- For emergency contraception within 120 hours after unprotected sexual intercourse.
- Taken orally, 1 tablet can be used up to 120 hours afterintercourse.
However, the earlier you use it, the more effective the treatment is.
Or as prescribed by physicians.
- Known hypersensitive to mifepristone or to any ingredient of the drug.
- Chronic adrenal failure.
- Severe uncontrolled asthma.
- Renal or hepatic impairment.
- Inherited porphyrias.
- Breast feeding.
- The side-effects of mifepristone besides delaying the onset of menses are uncommon and mild: Bleeding, nausea, vomiting, diarrhea, lower abdominal pain, fatigue, headache, dizziness, breast tenderness.
- More than 50% of the women had menstruation within 2 days of the expected date and about 9% of the women had a delay of more than 7 days at the onset of the first menses after treatment.
- Emergency contraception is a palliative, use only in case of emergency and it could not be replaced regular contraception. Women who present for repeated courses of emergency contraception should be advised to consider a long-term method of contraception.
- Emergency contraception could not have the desired effect in all of cases. If the unprotected sexual intercourse time was not determined or the women have had an unprotected sexual intercourse over 120 hours in one period, pregnancy may occur. So, treatment with mifepristone 10 mg after the second sexual intercourse may be ineffective. If the period is later than 5 days, unusual haemorrhagic on the day of the period is expected, or pregnancy is suspected due to any other causes, patients have to determine that pregnancy does not occur.
- Unprotected intercourse after treatment can increase the risk of an unwanted pregnancy.
- Should not repeat treatment in one period because of the risk of menstruation disorder.
- Should be used with care in patients with less severe asthma or with chronic obstructive airways diseases, haemorrhagic or cardiovascular disease or associated risk factors, or anaemia.
- Should be used with care in patients receiving long-term corticosteroid treatment; a corticosteroid may need to be given if acute adrenal suppression is suspected.
- Care is also required in patients receiving anticoagulants because of the increased risk of severe bleeding.
- Aspirin and NSAIDs should be avoided to use concomitantly with mifepristone because of a theoretical risk that prostaglandin synthetase inhibitors may alter the efficacy of mifepristone.
- Mifepristone should not be used during pregnancy, and the drug can not cause an abortion.
The dose of 10 mg is too low to cause an abortion but it cannot be excluded that in a few cases, a bleeding could be induced if the woman is pregnant.
- Mifepristone is excreted in human milk. Since the effects of mifepristone on infants are unknown, breast-feeding women should consult with their health care provider to decide if they should discard their breast milk for a few days following administration of the medications.
- Effects on ability to drive and use machines: None known.
- 4 years from manufacture date.
- STADA BRANCH VIETNAM - VIETNAM
- 1 Box 1 Capsules
- Store at dry, cool place (under 30oC).
- Protect from direct sunlight.
- Keep out of reach of children.
|Formulation||Pill/ Tablet/ Capsule|
|Package||Box (1 blister x 1 tablets)|
|Country of Manufacture||Vietnam|